Global Hereditary Angioedema Drug Sales Market Report 2017

Name: Global Hereditary Angioedema Drug Sales Market Report 2017
Brand: QYResearch
SKU: GD226A16E59PEN
Price: 4000 USD
Availability: InStock

October 2017 | 101 pages | ID: GD226A16E59PEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the global Hereditary Angioedema Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Hereditary Angioedema Drug for these regions, from 2012 to 2022 (forecast), covering

United States
China
Europe
Japan
Southeast Asia
India

Global Hereditary Angioedema Drug market competition by top manufacturers/players, with Hereditary Angioedema Drug sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

By Product

C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

By Route of Administration

Oral
Intravenous
Subcutaneous Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hereditary Angioedema Drug for each application, including

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Hereditary Angioedema Drug Sales Market Report 2017

1 HEREDITARY ANGIOEDEMA DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Hereditary Angioedema Drug
1.2 Classification of Hereditary Angioedema Drug by Product Category
  1.2.1 Global Hereditary Angioedema Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Hereditary Angioedema Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 C1 Esterase Inhibitor
  1.2.4 Kallikrein Inhibitor
  1.2.5 Selective Bradykinin B2 Receptor Antagonist
1.3 Global Hereditary Angioedema Drug Market by Application/End Users
  1.3.1 Global Hereditary Angioedema Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Drug Market by Region
  1.4.1 Global Hereditary Angioedema Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.3 China Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.4 Europe Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.5 Japan Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.7 India Hereditary Angioedema Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Hereditary Angioedema Drug (2012-2022)
  1.5.1 Global Hereditary Angioedema Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Hereditary Angioedema Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL HEREDITARY ANGIOEDEMA DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Hereditary Angioedema Drug Market Competition by Players/Suppliers
  2.1.1 Global Hereditary Angioedema Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Hereditary Angioedema Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Hereditary Angioedema Drug (Volume and Value) by Type
  2.2.1 Global Hereditary Angioedema Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Global Hereditary Angioedema Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Hereditary Angioedema Drug (Volume and Value) by Region
  2.3.1 Global Hereditary Angioedema Drug Sales and Market Share by Region (2012-2017)
  2.3.2 Global Hereditary Angioedema Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Hereditary Angioedema Drug (Volume) by Application

3 UNITED STATES HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Hereditary Angioedema Drug Sales and Value (2012-2017)
  3.1.1 United States Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  3.1.2 United States Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
  3.1.3 United States Hereditary Angioedema Drug Sales Price Trend (2012-2017)
3.2 United States Hereditary Angioedema Drug Sales Volume and Market Share by Players
3.3 United States Hereditary Angioedema Drug Sales Volume and Market Share by Type
3.4 United States Hereditary Angioedema Drug Sales Volume and Market Share by Application

4 CHINA HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Hereditary Angioedema Drug Sales and Value (2012-2017)
  4.1.1 China Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  4.1.2 China Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
  4.1.3 China Hereditary Angioedema Drug Sales Price Trend (2012-2017)
4.2 China Hereditary Angioedema Drug Sales Volume and Market Share by Players
4.3 China Hereditary Angioedema Drug Sales Volume and Market Share by Type
4.4 China Hereditary Angioedema Drug Sales Volume and Market Share by Application

5 EUROPE HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Hereditary Angioedema Drug Sales and Value (2012-2017)
  5.1.1 Europe Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  5.1.2 Europe Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Hereditary Angioedema Drug Sales Price Trend (2012-2017)
5.2 Europe Hereditary Angioedema Drug Sales Volume and Market Share by Players
5.3 Europe Hereditary Angioedema Drug Sales Volume and Market Share by Type
5.4 Europe Hereditary Angioedema Drug Sales Volume and Market Share by Application

6 JAPAN HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Hereditary Angioedema Drug Sales and Value (2012-2017)
  6.1.1 Japan Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  6.1.2 Japan Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Hereditary Angioedema Drug Sales Price Trend (2012-2017)
6.2 Japan Hereditary Angioedema Drug Sales Volume and Market Share by Players
6.3 Japan Hereditary Angioedema Drug Sales Volume and Market Share by Type
6.4 Japan Hereditary Angioedema Drug Sales Volume and Market Share by Application

7 SOUTHEAST ASIA HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Hereditary Angioedema Drug Sales and Value (2012-2017)
  7.1.1 Southeast Asia Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Hereditary Angioedema Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Hereditary Angioedema Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Hereditary Angioedema Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Hereditary Angioedema Drug Sales Volume and Market Share by Application

8 INDIA HEREDITARY ANGIOEDEMA DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Hereditary Angioedema Drug Sales and Value (2012-2017)
  8.1.1 India Hereditary Angioedema Drug Sales and Growth Rate (2012-2017)
  8.1.2 India Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
  8.1.3 India Hereditary Angioedema Drug Sales Price Trend (2012-2017)
8.2 India Hereditary Angioedema Drug Sales Volume and Market Share by Players
8.3 India Hereditary Angioedema Drug Sales Volume and Market Share by Type
8.4 India Hereditary Angioedema Drug Sales Volume and Market Share by Application

9 GLOBAL HEREDITARY ANGIOEDEMA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Pharming Group NV
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Hereditary Angioedema Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Shire plc
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Hereditary Angioedema Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Shire plc Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 CSL Limited
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Hereditary Angioedema Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 iBio Inc.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Hereditary Angioedema Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 iBio Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 BioCryst Pharmaceuticals, Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Hereditary Angioedema Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Ionis Pharmaceuticals, Inc.
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Hereditary Angioedema Drug Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview

10 HEREDITARY ANGIOEDEMA DRUG MAUFACTURING COST ANALYSIS

10.1 Hereditary Angioedema Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Hereditary Angioedema Drug
10.3 Manufacturing Process Analysis of Hereditary Angioedema Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Hereditary Angioedema Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL HEREDITARY ANGIOEDEMA DRUG MARKET FORECAST (2017-2022)

14.1 Global Hereditary Angioedema Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Hereditary Angioedema Drug Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Hereditary Angioedema Drug Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Hereditary Angioedema Drug Price and Trend Forecast (2017-2022)
14.2 Global Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Hereditary Angioedema Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Hereditary Angioedema Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Hereditary Angioedema Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Hereditary Angioedema Drug Sales Forecast by Type (2017-2022)
  14.3.2 Global Hereditary Angioedema Drug Revenue Forecast by Type (2017-2022)
  14.3.3 Global Hereditary Angioedema Drug Price Forecast by Type (2017-2022)
14.4 Global Hereditary Angioedema Drug Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Hereditary Angioedema Drug
Figure Global Hereditary Angioedema Drug Sales Volume Comparison (MT) by Type (2012-2022)
Figure Global Hereditary Angioedema Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure C1 Esterase Inhibitor Product Picture
Figure Kallikrein Inhibitor Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure Global Hereditary Angioedema Drug Sales Comparison (MT) by Application (2012-2022)
Figure Global Sales Market Share of Hereditary Angioedema Drug by Application in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Hereditary Angioedema Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate (2012-2022)
Figure Global Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Hereditary Angioedema Drug Sales Volume (MT) (2012-2017)
Table Global Hereditary Angioedema Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table Global Hereditary Angioedema Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Hereditary Angioedema Drug Sales Share by Players/Suppliers
Figure 2017 Hereditary Angioedema Drug Sales Share by Players/Suppliers
Figure Global Hereditary Angioedema Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Hereditary Angioedema Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Hereditary Angioedema Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Hereditary Angioedema Drug Revenue Share by Players
Table 2017 Global Hereditary Angioedema Drug Revenue Share by Players
Table Global Hereditary Angioedema Drug Sales (MT) and Market Share by Type (2012-2017)
Table Global Hereditary Angioedema Drug Sales Share (MT) by Type (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure Global Hereditary Angioedema Drug Sales Growth Rate by Type (2012-2017)
Table Global Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Hereditary Angioedema Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure Global Hereditary Angioedema Drug Revenue Growth Rate by Type (2012-2017)
Table Global Hereditary Angioedema Drug Sales Volume (MT) and Market Share by Region (2012-2017)
Table Global Hereditary Angioedema Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Sales Growth Rate by Region in 2016
Table Global Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Hereditary Angioedema Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Revenue Growth Rate by Region in 2016
Table Global Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Hereditary Angioedema Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Revenue Market Share by Region in 2016
Table Global Hereditary Angioedema Drug Sales Volume (MT) and Market Share by Application (2012-2017)
Table Global Hereditary Angioedema Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Application (2012-2017)
Figure Global Hereditary Angioedema Drug Sales Market Share by Application (2012-2017)
Figure United States Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure United States Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table United States Hereditary Angioedema Drug Sales Volume (MT) by Players (2012-2017)
Table United States Hereditary Angioedema Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Volume Market Share by Players in 2016
Table United States Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table United States Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table United States Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2017)
Table United States Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure China Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure China Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table China Hereditary Angioedema Drug Sales Volume (MT) by Players (2012-2017)
Table China Hereditary Angioedema Drug Sales Volume Market Share by Players (2012-2017)
Figure China Hereditary Angioedema Drug Sales Volume Market Share by Players in 2016
Table China Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table China Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure China Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table China Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2017)
Table China Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure China Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure Europe Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Europe Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Europe Hereditary Angioedema Drug Sales Volume (MT) by Players (2012-2017)
Table Europe Hereditary Angioedema Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Hereditary Angioedema Drug Sales Volume Market Share by Players in 2016
Table Europe Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table Europe Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table Europe Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2017)
Table Europe Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure Japan Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Hereditary Angioedema Drug Sales Volume (MT) by Players (2012-2017)
Table Japan Hereditary Angioedema Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Hereditary Angioedema Drug Sales Volume Market Share by Players in 2016
Table Japan Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table Japan Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table Japan Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2017)
Table Japan Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Sales Volume (MT) by Players (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure India Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table India Hereditary Angioedema Drug Sales Volume (MT) by Players (2012-2017)
Table India Hereditary Angioedema Drug Sales Volume Market Share by Players (2012-2017)
Figure India Hereditary Angioedema Drug Sales Volume Market Share by Players in 2016
Table India Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table India Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure India Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table India Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2017)
Table India Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure India Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Table Pharming Group NV Basic Information List
Table Pharming Group NV Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales Global Market Share (2012-2017
Figure Pharming Group NV Hereditary Angioedema Drug Revenue Global Market Share (2012-2017)
Table Shire plc Basic Information List
Table Shire plc Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales Global Market Share (2012-2017
Figure Shire plc Hereditary Angioedema Drug Revenue Global Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales Global Market Share (2012-2017
Figure CSL Limited Hereditary Angioedema Drug Revenue Global Market Share (2012-2017)
Table iBio Inc. Basic Information List
Table iBio Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales Global Market Share (2012-2017
Figure iBio Inc. Hereditary Angioedema Drug Revenue Global Market Share (2012-2017)
Table BioCryst Pharmaceuticals, Inc. Basic Information List
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Global Market Share (2012-2017
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Global Market Share (2012-2017)
Table Ionis Pharmaceuticals, Inc. Basic Information List
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Global Market Share (2012-2017
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Drug
Figure Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure Hereditary Angioedema Drug Industrial Chain Analysis
Table Raw Materials Sources of Hereditary Angioedema Drug Major Players in 2016
Table Major Buyers of Hereditary Angioedema Drug
Table Distributors/Traders List
Figure Global Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Global Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Hereditary Angioedema Drug Price (USD/Kg) and Trend Forecast (2017-2022)
Table Global Hereditary Angioedema Drug Sales Volume (MT) Forecast by Regions (2017-2022)
Figure Global Hereditary Angioedema Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Hereditary Angioedema Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Hereditary Angioedema Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Hereditary Angioedema Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Hereditary Angioedema Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure China Hereditary Angioedema Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Hereditary Angioedema Drug Sales (MT) Forecast by Type (2017-2022)
Figure Global Hereditary Angioedema Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Hereditary Angioedema Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Hereditary Angioedema Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Hereditary Angioedema Drug Price (USD/Kg) Forecast by Type (2017-2022)
Table Global Hereditary Angioedema Drug Sales (MT) Forecast by Application (2017-2022)
Figure Global Hereditary Angioedema Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Global Hereditary Angioedema Drug Sales Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports